(Q48619414)

13 February 2018

title

Opposite responses in the striato-nigral substance P system to D1 and D2 receptor activation (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90666-6

29 August 2023

0 references

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90666-6

29 August 2023

author name string

P. K. Sonsalla

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6208043

29 August 2023

J. W. Gibb

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6208043

29 August 2023

G. R. Hanson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6208043

29 August 2023

language of work or name

English

0 references

publication date

1 October 1984

1 reference

13 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0014299984906666?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90666-6

https://api.elsevier.com/content/article/PII:0014299984906666?httpAccept=text/plain

29 August 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90666-6

European Journal of Pharmacology

29 August 2023

published in

1 reference

13 February 2018

volume

105

1 reference

13 February 2018

issue

1-2

1 reference

13 February 2018

page(s)

185-187

1 reference

13 February 2018

Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90666-6

Response of striatonigral substance P systems to a dopamine receptor agonist and antagonist

29 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90666-6

Haloperidol-induced reduction of nigral substance P-like immunoreactivity: a probe for the interactions between dopamine and substance P neuronal systems

29 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90666-6

Elevation of substance P-like immunoreactivity in rat central nervous system by protease inhibitors

29 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90666-6

Substance P content of substantia nigra after chronic treatment with antischizophrenic drugs

29 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90666-6

Multiple receptors for dopamine

29 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90666-6

Acute changes in nigral substance P content induced by drugs acting on dopamine, muscarine and GABA receptors

29 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90666-6

The central effects of a novel dopamine agonist

29 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(84)90666-6

29 August 2023

Identifiers

1 reference

13 February 2018

release_cicoy4kdl5gb3faxmo4tfbzzfi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cicoy4kdl5gb3faxmo4tfbzzfi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

13 February 2018